Teresa Sevilla

Dr. Teresa Sevilla

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2010 in Circulation
Verified
Journal Article
Closed access
PDF file
JLJavier López-Díaz
Javier López-Díaz
ARAna Revilla
Ana Revilla
IVIsidre Vilacosta
Isidre Vilacosta
TSTeresa Sevilla
Teresa Sevilla
EVEduardo Villacorta
Eduardo Villacorta
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar
Background— The influence of age on the main epidemiological, clinical, echocardiographic, microbiological, and prognostic features of patients with infective endocarditis remains unknown. We present the series with the largest numbers and range of ages of subjects to date that analyzes the influence of age on the main characteristics of patients with isolated left-sided infective endocarditis. Furthermore, this series is the first one in which patients have been distributed according to age quartile. Methods and Results— A total of 600 episodes of left-sided endocarditis consecutively diagnosed in 3 tertiary centers were stratified into age-specific quartiles and 107 variables compared between the different groups. With increasing age, the percentage of women, previous heart disease, predisposing disease (diabetes mellitus and cancer), and infection by enterococci and Streptococcus bovis also increased. Valvular insufficiency and perforation and S taphylococcus aureus infection were more common in younger patients. The therapeutic approach differed depending on patient age because of the growing proportion of older patients who only received medical treatment. Clinical course and hospital prognosis were worse in the older patients because of increased surgical mortality among them. Conclusions— Increasing age is associated with less valvular impairment (insufficiency and perforation), a more favorable microbiological profile, and increased surgical mortality among adults with left-sided infective endocarditis.

1 August 2012 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar
IVIsidre Vilacosta
Isidre Vilacosta
JLJavier López-Díaz
Javier López-Díaz
ARAna Revilla
Ana Revilla
RARoman Arnold
Roman Arnold
MRMaría J. Rollán
María J. Rollán

9 November 2012 in European Heart Journal
Verified
Journal Article
Open access
PDF file
JLJavier López-Díaz
Javier López-Díaz
TSTeresa Sevilla
Teresa Sevilla
IVIsidre Vilacosta
Isidre Vilacosta
CSCristina Sarriá
Cristina Sarriá
ARAna Revilla
Ana Revilla
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar
Persistent infection is not a scientific evidence-based definition. The guidelines of infective endocarditis (IE) establish a cut-off point of 7–10 days, which is arbitrary and probably too long. Our hypothesis is that persistent positive blood cultures after 48–72 h from the initiation of antibiotic therapy are associated with a worse prognosis in patients with left-sided IE. We repeated blood cultures after 48–72 h of the initiation of the antibiotic treatment in 407 patients with left-sided IE of a total of 692 episodes consecutively diagnosed from 1996 to 2011. We have compared the profile of patients whose blood cultures became negative and those with persistent positive blood cultures. We performed a multivariate logistic regression model to determine the prognostic implication of persistent positive blood cultures. Of 256 patients with positive blood cultures at admission, 89 (35%) had persistent positive cultures after 48–72 h from the initiation of the antibiotic treatment. Persistent positive blood cultures (OR: 2.1; 95% CI: 1.2–3.6), age (OR: 1.026; 95% CI: 1.007–1.046), Staphylococcus aureus infection (OR: 3.3; 95% CI: 1.6–6.6), heart failure (OR: 2.8; 95% CI: 1.6–4.7), and renal failure (OR: 2.9; 95% CI: 1.8–4.9) were found to be independently associated with higher in-hospital mortality. The presence of persistent positive blood cultures is an independent risk factor for in-hospital mortality which doubles the risk of death of patients with left-sided IE. It should be taken into account in the risk stratification of these patients.

1 December 2014 in Medicine
Verified
Journal Article
Open access
COCarlos Ortiz-Bautista
Carlos Ortiz-Bautista
JLJavier López-Díaz
Javier López-Díaz
HGHéctor García
Héctor García
TSTeresa Sevilla
Teresa Sevilla
ARAna Revilla
Ana Revilla
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar
From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no cardiac devices. Our objective is to describe and compare the clinical profile and outcome of these groups of patients. Every episode of infective endocarditis (IE) consecutively diagnosed in 3 tertiary centers from 1996 to 2012 was included in an ongoing multipurpose database. We assessed 85 epidemiologic, clinical, echocardiographic, and outcome variables in patients with isolated RSIE. A bivariated comparative analysis between the 3 groups was conducted.Among 866 IE episodes, 121 were classified as isolated RSIE (14%): 36 IDUs (30%), 65 cardiac device carriers (54%), and 20 "3 noes" group (16%). IDUs were mainly young men (36 ± 7 years) without previous heart disease, few comorbidities, and frequent previous endocarditis episodes (28%). Human immunodeficiency virus infection was frequent (69%). Cardiac device carriers were older (66 ± 15 years) and had less comorbidities (34%). Removal of the infected device was performed in 91% of the patients without any death. The "3 noes" endocarditis group was composed mainly by middle-age men (56 ± 18 years), health care related infections (50%), and had many comorbidities (75%). Whereas Staphylococcus aureus were the most frequent cause in IDUs (72% vs 34% in device carriers and 34% in the "3 noes" group, P = 0.001), coagulase negative Staphylococci predominated in the device carriers (58% vs 11% in drug users and 35% in the "3 noes", P < 0.001). Significant differences in mortality were found (17% in drug users, 3% in device carriers, and 30% in the "3 noes" group; P < 0.001). These results suggest that RSIE should be separated into 3 groups (IDUs, cardiac device carriers, and the "3 noes") and considered as independent entities as there are relevant epidemiologic, clinical, microbiological, echocardiographic, and prognostic differences among them.

1 September 2008 in American Heart Journal
Verified
Journal Article
Closed access
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar
JLJavier López-Díaz
Javier López-Díaz
ARAna Revilla
Ana Revilla
IVIsidre Vilacosta
Isidre Vilacosta
PTPilar Tornos
Pilar Tornos
AIAlberto Igual
Alberto Igual

1 May 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
COCarlos Ortiz-Bautista
Carlos Ortiz-Bautista
JLJavier López-Díaz
Javier López-Díaz
PGPablo Elpidio García-Granja
Pablo Elpidio García-Granja
TSTeresa Sevilla
Teresa Sevilla
IVIsidre Vilacosta
Isidre Vilacosta
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar